Erratum: Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer [Ann Oncol, 27,(2016) (2032-2038)] DOI: 10.1093/annonc/mdw317

Filip Janku, L. K. Johnson, D. D. Karp, J. T. Atkins, P. A. Singleton, J. Moss

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer [Ann Oncol, 27,(2016) (2032-2038)] DOI: 10.1093/annonc/mdw317'. Together they form a unique fingerprint.

Medicine & Life Sciences